Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...

One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

Thomas Kwan, initially pleaded not guilty to attempted murder but reversed his plea after prosecutors presented their evidence.

Several companies and labs are betting the latest generation of chatbots could make useful research assistants, accelerating ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...

Pfizer’s CEO Albert Bourla, who was key in securing the Covid-19 vaccine partnership with BioNTech, admitted in an investor ...

Investors are pouring cash into artificial intelligence-related health care startups at twice the rate of the AI tech sector ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

California vetoes AI bill, Google launches Gemini Live, Microsoft adds Copilot features, DeepMind partners with BioNTech.

The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...